Alpine 4 (ALPP) 10-Q 4 Nov 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 01, 2021
Registrant CIK	0001606698
Fiscal Year End	--12-31
Registrant Name	Alpine 4 Holdings, Inc.
SEC Form	10-Q
Period End date	Sep. 30, 2021
Tax Identification Number (TIN)	46-5482689
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Shell Company	false
Small Business	true
Emerging Growth Company	true
Ex Transition Period	true
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-55205
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2525 E Arizona Biltmore Circle
Entity Address, Address Line Two	Suite 237
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85016
City Area Code	480
Local Phone Number	702-2431
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Common Class A
Number of common stock shares outstanding		149,609,780
Common Class B
Number of common stock shares outstanding		8,673,088
Common Class C
Number of common stock shares outstanding		12,500,200

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash	$ 5,425,913	$ 277,738
Restricted Cash	0	444,845
Accounts receivable, net	12,990,229	6,484,869
Contract assets	3,655,625	717,421
Inventory, net	9,632,121	2,666,602
Prepaid expenses and other current assets	1,272,760	32,301
Total current assets	32,976,648	10,623,776
Investment in equity securities	1,350,000	0
Property and equipment, net	27,320,596	19,299,286
Intangible asset, net	29,001,665	7,743,084
Right of use assets, net	347,712	581,311
Goodwill	5,866,454	2,084,982
Other non-current assets	248,257	401,744
TOTAL ASSETS	97,111,332	40,734,183
CURRENT LIABILITIES:
Accounts payable	5,653,158	4,854,467
Accrued expenses	4,253,987	2,872,202
Contract liabilities	3,486,331	233,485
Line of credit	3,718,972	0
Notes payable, current portion	5,811,241	7,100,911
Notes payable, related parties	3,000	238,651
Convertible notes payable, current	7,500	562,242
Financing lease obligation, current portion	628,574	639,527
Operating lease obligation, current portion	135,207	334,500
Total current liabilities	23,697,970	16,835,985
Notes payable, net of current portion	7,522,462	15,201,450
Convertible notes payable, net of current portion	0	1,100,635
Financing lease obligations, net of current portion	15,489,693	15,687,176
Operating lease obligations, net of current portion	219,682	269,030
Deferred tax liability	428,199	428,199
TOTAL LIABILITIES	47,358,006	49,522,475
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	0	0
Additional paid-in capital	96,306,820	30,991,978
Accumulated deficit	(46,570,554)	(39,795,401)
Total stockholders' equity (deficit)	49,753,326	(8,788,292)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	97,111,332	40,734,183
Series B Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	5	5
Total stockholders' equity (deficit)	5	5
Series C Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	171	171
Total stockholders' equity (deficit)	171	171
Series D Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	143	0
Total stockholders' equity (deficit)	143	0
Common Class A
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	14,624	12,636
Total stockholders' equity (deficit)	14,624	12,636
Common Class B
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	867	902
Total stockholders' equity (deficit)	867	902
Common Class C
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	1,250	1,417
Total stockholders' equity (deficit)	$ 1,250	$ 1,417

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Series B Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Shares Authorized	100	100
Preferred Stock, Shares Issued	5	5
Preferred Stock, Shares Outstanding	5	5
Series C Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 3.50	$ 3.50
Preferred Stock, Shares Authorized	2,028,572	2,028,572
Preferred Stock, Shares Issued	1,714,286	1,714,286
Preferred Stock, Shares Outstanding	1,714,286	1,714,286
Series D Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 3.50	$ 3.50
Preferred Stock, Shares Authorized	1,628,572	1,628,572
Preferred Stock, Shares Issued	1,432,244	0
Preferred Stock, Shares Outstanding	1,432,244	0
Common Class A
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	195,000,000	195,000,000
Common Stock, Shares, Issued	146,214,650	126,363,158
Common Stock, Shares, Outstanding	146,214,650	126,363,158
Common Class B
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Shares, Issued	8,673,088	9,023,088
Common Stock, Shares, Outstanding	8,673,088	9,023,088
Common Class C
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	15,000,000	15,000,000
Common Stock, Shares, Issued	12,500,200	14,162,267
Common Stock, Shares, Outstanding	12,500,200	14,162,267

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Revenue	$ 17,398,316	$ 8,729,633	$ 39,938,585	$ 26,608,093
Cost of revenue	12,950,180	7,390,406	30,771,770	21,553,106
Gross Profit	4,448,136	1,339,227	9,166,815	5,054,987
Operating expenses:
General and administrative expenses	5,539,465	1,911,278	17,719,228	7,225,280
Impairment loss of intangible assets and goodwill	0	0	0	1,111,600
Research and development	581,131	0	1,096,333	0
Total operating expenses	6,120,596	1,911,278	18,815,561	8,336,880
Loss from operations	(1,672,460)	(572,051)	(9,648,746)	(3,281,893)
Other income (expenses)
Interest expense	(537,882)	(1,139,462)	(3,226,192)	(3,694,531)
Change in value of derivative liability	0	0	0	2,298,609
Gain (loss) on extinguishment of debt	0	253,063	803,079	344,704
Gain on forgiveness of debt	4,307,291	0	4,896,573	0
Bargain purchase gain	0	64,371	0	64,371
Change in fair value of contingent consideration	0	0	0	500,000
Other income	438,701	(5,783)	454,191	56,352
Total other income (expenses)	4,208,110	(827,811)	2,927,651	(430,495)
Income (loss) before income tax	2,535,650	(1,399,862)	(6,721,095)	(3,712,388)
Income tax	54,058	0	54,058	0
Net income (loss)	$ 2,481,592	$ (1,399,862)	$ (6,775,153)	$ (3,712,388)
Weighted average shares outstanding:
Weighted Average Number of Shares Outstanding, Basic	166,964,408	131,934,084	161,118,324	130,111,673
Weighted Average Number of Shares Outstanding, Diluted	168,627,907	131,934,084	161,118,324	138,238,550
Earnings Per Share, Basic	$ 0.01	$ (0.01)	$ (0.04)	$ (0.03)
Earnings Per Share, Diluted	$ 0.01	$ (0.01)	$ (0.04)	$ (0.04)

Consolidated Statements Changes

Consolidated Statements Changes in Stockholders' Equity (Deficit) - USD ($)	Additional Paid-in Capital	Retained Earnings	Total	Series B Preferred Stock	Series C Preferred Stock	Series D Preferred Stock	Common Class A	Common Class B	Common Class C
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2019	$ 19,763,883	$ (31,745,528)	$ (11,970,142)	$ 0	$ 0	$ 0	$ 10,007	$ 500	$ 996
Shares, Outstanding, Beginning Balance at Dec. 31, 2019				0	0	0	100,070,161	5,000,000	9,955,200
Stock Issued During Period, Value, New Issues	249,606	0	250,000	$ 0	$ 0	$ 0	$ 394	$ 0	$ 0
Stock Issued During Period, Shares, New Issues							3,941,753
Issuance of shares of common stock for modification of debt	330,204	0	330,528	$ 0	0	0	$ 162	0	$ 162
Issuance of shares of common stock for modification of debt, shares				0			1,617,067		1,617,067
Issuance Of Shares Of Common Stock For Penalty	44,670	0	44,700	$ 0	0	0	$ 30	0	$ 0
Issuance Of Shares Of Common Stock For Penalty, Shares				0			300,000
Issuance of shares of common stock for convertible note payable and accrued interest	696,868	0	697,332	$ 0	0	0	$ 464	0	0
Issuance of shares of common stock for convertible note payable and accrued interest, shares				0			4,648,879
Issuance Of Shares Of Common Stock For Compensation, Value	603,061	0	603,463	$ 0	0	0	$ 0	$ 402	0
Issuance Of Shares Of Common Stock For Compensation, Shares								4,023,088
Issuance Of Shares Of Series B Preferred Stock, Value	0	0	5	$ 5	0	0	0	$ 0	0
Issuance Of Shares Of Series B Preferred Stock, Shares				5
Share-based compensation expense	19,556	0	19,556	$ 0	0	0	0	0	0
Net income (loss)	0	250,388	250,388	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2020	21,707,848	(31,495,140)	(9,774,170)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Mar. 31, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2019	19,763,883	(31,745,528)	(11,970,142)	$ 0	$ 0	$ 0	$ 10,007	$ 500	$ 996
Shares, Outstanding, Beginning Balance at Dec. 31, 2019				0	0	0	100,070,161	5,000,000	9,955,200
Net income (loss)			(3,712,388)
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2020	21,870,874	(35,457,916)	(13,573,620)	$ 5	$ 0	$ 0	$ 11,357	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Sep. 30, 2020				5	0	0	113,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2020	21,707,848	(31,495,140)	(9,774,170)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Beginning Balance at Mar. 31, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Share-based compensation expense	19,556	0	19,556	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Net income (loss)	0	(2,562,914)	(2,562,914)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2020	21,727,404	(34,058,054)	(12,317,528)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Jun. 30, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Stock Issued During Period, Value, New Issues	123,700	0	124,000	$ 0	$ 0	$ 0	$ 300	$ 0	$ 0
Stock Issued During Period, Shares, New Issues							3,000,000
Share-based compensation expense	19,770	0	19,770	0	0	0	$ 0	0	0
Net income (loss)	0	(1,399,862)	(1,399,862)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2020	21,870,874	(35,457,916)	(13,573,620)	$ 5	$ 0	$ 0	$ 11,357	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Sep. 30, 2020				5	0	0	113,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	30,991,978	(39,795,401)	(8,788,292)	$ 5	$ 171	$ 0	$ 12,636	$ 902	$ 1,417
Shares, Outstanding, Beginning Balance at Dec. 31, 2020				5	1,714,286	0	126,363,158	9,023,088	14,162,267
Issuance Of Shares Of Common Stock For Cash, Net Of Offering Costs, Value	54,301,997	0	54,302,982	$ 0	$ 0	$ 0	$ 985	$ 0	$ 0
Issuance Of Shares Of Common Stock For Cash, Net Of Offering Costs, Shares							9,857,397
Issuance of shares of common stock for convertible note payable and accrued interest	109,760	0	109,830	0	0	0	$ 70	0	0
Issuance of shares of common stock for convertible note payable and accrued interest, shares							702,877
Stock Issued During Period, Value, Acquisitions	6,653,166	0	6,653,309	0	0	$ 143	$ 0	0	0
Stock Issued During Period, Shares, Acquisitions						1,432,244
Repurchase Of Class C Common Stock, Value	(185,845)	0	(185,850)	0	0	$ 0	0	0	(5)
Share-based compensation expense	19,341	0	19,341	0	0	0	0	0	0
Beneficial conversion feature on convertible notes	92,428	0	92,428	0	0	0	0	0	0
Net income (loss)	0	(6,129,468)	(6,129,468)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	91,982,825	(45,924,869)	46,074,280	$ 5	$ 171	$ 143	$ 13,691	$ 902	$ 1,412
Shares, Outstanding, Ending Balance at Mar. 31, 2021				5	1,714,286	1,432,244	136,923,432	9,023,088	14,117,267
Repurchase Of Class C Common Stock, Shares									(45,000)
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	30,991,978	(39,795,401)	(8,788,292)	$ 5	$ 171	$ 0	$ 12,636	$ 902	$ 1,417
Shares, Outstanding, Beginning Balance at Dec. 31, 2020				5	1,714,286	0	126,363,158	9,023,088	14,162,267
Net income (loss)			(6,775,153)
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2021	96,306,820	(46,570,554)	49,753,326	$ 5	$ 171	$ 143	$ 14,624	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Sep. 30, 2021				5	1,714,286	1,432,244	146,214,650	8,673,088	12,500,200
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2021	91,982,825	(45,924,869)	46,074,280	$ 5	$ 171	$ 143	$ 13,691	$ 902	$ 1,412
Shares, Outstanding, Beginning Balance at Mar. 31, 2021				5	1,714,286	1,432,244	136,923,432	9,023,088	14,117,267
Issuance of shares of common stock for convertible note payable and accrued interest	1,419,034	0	1,419,568	$ 0	$ 0	$ 0	$ 534	$ 0	$ 0
Issuance of shares of common stock for convertible note payable and accrued interest, shares							5,295,308
Stock Issued During Period, Value, Acquisitions	2,535,007	0	2,535,071	0	0	0	$ 64	0	0
Stock Issued During Period, Shares, Acquisitions							643,010
Conversion of Class C to Class A, Value	0	0	0	0	0	0	$ 162	0	$ (162)
Conversion of Class C to Class A, Shares							1,617,067		(1,617,067)
Conversion of Class B to Class A, Value	0	0	0	0	0	0	$ 35	$ (35)	$ 0
Conversion of Class B to Class A, Shares							350,000	(350,000)
Share-based compensation expense	7,988	0	7,988	0	0	0	$ 0	$ 0	0
Net income (loss)	0	(3,127,277)	(3,127,277)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2021	95,944,854	(49,052,146)	46,909,630	$ 5	$ 171	$ 143	$ 14,486	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Jun. 30, 2021				5	1,714,286	1,432,244	144,828,817	8,673,088	12,500,200
Issuance of shares of common stock for convertible note payable and accrued interest	357,362	0	357,500	$ 0	$ 0	$ 0	$ 138	$ 0	$ 0
Issuance of shares of common stock for convertible note payable and accrued interest, shares							1,385,833
Conversion of Class C to Class A, Shares							1,617,067		(1,617,067)
Conversion of Class B to Class A, Shares							350,000	(350,000)
Share-based compensation expense	4,604	0	4,604	0	0	0	$ 0	$ 0	$ 0
Net income (loss)	0	2,481,592	2,481,592	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2021	$ 96,306,820	$ (46,570,554)	$ 49,753,326	$ 5	$ 171	$ 143	$ 14,624	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Sep. 30, 2021				5	1,714,286	1,432,244	146,214,650	8,673,088	12,500,200

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Net Cash Provided by (Used in) Operating Activities
Net income (loss)	$ (6,775,153)	$ (3,712,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,851,969	1,582,604
Gain on extinguishment of debt	(803,079)	(344,704)
Gain of forgiveness of debt	(4,896,573)	0
Change in fair value of contingent consideration	0	(500,000)
Change in fair value of derivative liabilities	0	(2,298,609)
Stock issued for penalties	0	44,700
Employee stock compensation	31,933	58,887
Amortization of debt discounts	1,436,052	507,534
Non-cash lease expense	328,628	200,165
Bargain purchase gain	0	(64,371)
Impairment loss of intangible asset and goodwill	0	1,111,600
Write off of inventory	0	127,919
Change in current assets and liabilities:
Increase (Decrease) in Receivables	(6,096,678)	2,542,306
Increase (Decrease) in Inventories	(4,343,866)	(146,925)
Capitalized Contract Cost, Amortization	(2,111,973)	158,978
Increase (Decrease) in Prepaid Expense	(696,471)	141,147
Increase (Decrease) in Accounts Payable	(17,460)	(661,933)
Increase (Decrease) in Accrued Liabilities	1,045,007	159,828
Increase (Decrease) in Contract with Customer, Liability	(835,632)	(71,548)
Operating lease liability	(343,670)	(189,503)
Increase (Decrease) in Deferred Revenue	0	(12,509)
Net cash used in operating activities	(21,226,966)	(1,366,822)
Net Cash Provided by (Used in) Investing Activities
Capital expenditures	(2,970,087)	(75,670)
Cash paid for equity investment	(350,000)	0
Cash paid for acquisitions	(16,824,000)	(2,513,355)
Cash assumed in acquisition	81,442	0
Net cash used in investing activities	(20,062,645)	(2,589,025)
Net Cash Provided by (Used in) Financing Activities
Proceeds from the sale of common stock, net of offering costs	54,302,982	374,000
Proceeds from issuances of notes payable, related parties	0	47,000
Proceeds from issuances of notes payable, non-related party	15,609	4,644,817
Proceeds from issuances of convertible notes payable	408,000	0
Proceeds from line of credit	3,718,972	0
Proceeds from financing lease	0	2,000,000
Repurchase of common stock	(185,850)	0
Repayments of notes payable, related party	(235,651)	(217,822)
Repayments of notes payable, non-related parties	(7,041,401)	(1,745,647)
Repayments of convertible notes payable	(1,680,964)	(270,294)
Repayment of line of credit	(2,821,033)	(660,764)
Cash paid on financing lease obligations	(487,723)	(355,094)
Net cash provided by financing activities	45,992,941	3,816,196
NET INCREASE (DECREASE) IN CASH AND RESTRICTED CASH	4,703,330	(139,651)
CASH AND RESTRICTED CASH, BEGINNING BALANCE	722,583	302,486
CASH AND RESTRICTED CASH, ENDING BALANCE	5,425,913	162,835
Supplemental Cash Flow Information
Interest Paid	1,593,255	2,857,895
Income Taxes Paid	54,058	0
Supplemental Cash Flow Elements
Penalty interest added to debt	0	15,000
Common stock issued for convertible note payable and accrued interest	1,886,898	697,332
Common stock issued for debt settlement	0	330,528
Issuance of note payable for acquisition	0	2,300,000
Common stock issued for acquisition	2,535,071	0
Common stock issued to settle unpaid salaries	0	603,463
ROU asset and operating lease obligation recognized under Topic 842	95,029	193,541
Remeasurement of finance lease liability	279,287	0
Equipment purchased on financing lease	0	756,990
Mortgage on property purchase	4,680,000	0
Accounts receivable converted to equity investment	1,000,000	0
Other asset reclassified to fixed asset	0	86,471
Issuance of shares of series D preferred stock for acquisition	6,653,309	0
Interest added to note payable - related party	0	134,185
Beneficial conversion feature on convertible notes	$ 92,428	$ 0

Note 1 - Organization and Basis

Note 1 - Organization and Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Notes
Note 1 - Organization and Basis of Presentation	Note 1 – Organization and Basis of Presentation The unaudited consolidated financial statements were prepared by Alpine 4 Holdings, Inc. (‘we,” “our,” or the "Company"), pursuant to the rules and regulations of the Securities Exchange Commission ("SEC"). The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") were omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company's Annual Report on Form 10-K filed with the SEC on April 15, 2021. The results for the nine months ended September 30, 2021, are not necessarily indicative of the results to be expected for the year ending December 31, 2021. The Company was incorporated under the laws of the State of Delaware on April 22, 2014. The Company was formed to serve as a vehicle to affect an asset acquisition, merger, exchange of capital stock, or other business combination with a domestic or foreign business. On March 2, 2021, the Company changed its name from Alpine 4 Technologies Ltd. to Alpine 4 Holdings, Inc. Effective April 1, 2016, the Company purchased all of the outstanding capital stock of Quality Circuit Assembly, Inc., a California corporation (“QCA”). Effective January 1, 2019, the Company purchased all of the outstanding capital stock or equity interests in Morris Sheet Metal Corp., an Indiana corporation (“MSM”); JTD Spiral, Inc., an Indiana corporation wholly owned by MSM; Morris Enterprises LLC, an Indiana limited liability company; and Morris Transportation LLC, an Indiana limited liability company (collectively “Morris”). Effective November 6, 2019, the Company purchased all of the outstanding capital stock and units of Deluxe Sheet Metal, Inc., an Indiana corporation, and DSM Holding, LLC, an Indiana limited liability company; and purchased certain real estate from Lonewolf Enterprises, LLC, an Indiana limited liability company (collectively “Deluxe”). Effective February 21, 2020, the Company purchased all of the outstanding units of Excel Fabrication, LLC., an Idaho limited liability company (“Excel”). Excel subsequently changed its name to Excel Construction Services, LLC. Effective December 15, 2020, the Company purchased the assets of Impossible Aerospace Corporation, a Delaware corporation (“IA”). Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”). On May 5, 2021, the Company acquired all of the outstanding shares of stock of Thermal Dynamics, Inc., a Delaware corporation (“TDI”). On May 10, 2021, the Company acquired all of the outstanding membership interests of KAI Enterprises, LLC, a Florida limited liability company, the sole asset of which was all of the outstanding membership interests of Alternative Laboratories, LLC, a Delaware limited liability company (“Alt Labs”). On October 20, 2021, after the period covered by this Report, the Company acquired 100% of the outstanding shares of Identified Technologies Corporation, a Delaware corporation (“Identified Technologies”). As of the date of this Report, the Company was a holding company owning, directly or indirectly, eleven companies: · · · · · · · · · · · Basis of presentation The accompanying consolidated financial statements present the balance sheets, statements of operations, stockholders' deficit and cash flows of the Company. The financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Liquidity The Company’s financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board (the “FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. While the Company experienced a loss for the nine months ended September 30, 2021, of $6.8 million, and had a negative cash flow used in operations, there were several significant one-time / non-recurring items included in the $6.8 million net loss. These non-recurring items totaled $2.2 million, consisting of $350 thousand in new acquisitions expenses captured in professional fees, and other costs, and $1.8 million for repurchase of RSUs. The Company received a total of approximately $54.0 million in February 2021 in the following two transactions: · · The Company has secured bank financing totaling $9.3 million ($8.3 million in Lines of Credit and $1.0 million in capital expenditures lines of credit availability) of which $5.6 million was unused at September 30, 2021. The Company plans to continue to generate additional revenue (and improve cash flows from operations) partly from the acquisitions of three operating companies which closed in May 2021 and October 2021 combined with improved gross profit performance from the existing operating companies. Based on the capital raise as indicated above and management’s plans to improve cash flows from operations, management believes the Company has sufficient working capital to satisfy the Company’s estimated liquidity needs for the next 12 months. The Company ended the September 30, 2021, quarter with approximately $5.4 million in cash and working capital of $9.3 million. As of the date of this Report, the Company had approximately $3.5 million in cash. During the nine months ended September 30, 2021, the Company paid down liabilities of approximately $13.1 million. In addition, approximately $7.2 million was used to build inventory and for capital expenditures. However, there is no assurance that management’s plans will be successful due to the current economic climate in the United States and globally.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Notes
Note 2 - Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Principles of consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of September 30, 2021 and December 31, 2020. Significant intercompany balances and transactions have been eliminated. Use of estimates The consolidated financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. In many instances, the Company could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of long-lived assets, valuation allowance for deferred tax assets and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2021 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2021 and beyond. COVID-19 did have a negative impact on the Company’s financial performance in 2020. During the nine months ended September 30, 2021, there was no impairment charge related to intangible assets and goodwill. Cash and Restricted Cash Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of September 30, 2021, and December 31, 2020, the Company had no cash equivalents. As of September 30, 2021, and December 31, 2020, the Company had $0 and $444,845 in restricted cash, respectively, for amounts held in escrow. The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows. September 30, December 31, 2021 2020 Cash $ 5,425,913 $ 277,738 Restricted cash - 444,845 Total cash and restricted cash shown in statement of cash flows $ 5,425,913 $ 722,583 Major Customers The Company had two customers that made up 16% and 18%, respectively, of accounts receivable as of September 30, 2021. The Company had two customers that made up 10% and 8%, respectively, of accounts receivable as of December 31, 2020. For the nine months ended September 30, 2021 and 2020, the Company had one customer that made up 13% and 10% of total revenues, respectively. Fair value measurements Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 Level 2 Level 3 The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates. As of September 30, 2021 and December 31, 2020, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis. Equity Investments The Company’s equity investments consist of investment in one private company in which the Company does not have the ability to exercise significant influence over their operating and financial activities. This investment is carried at cost as there is no market for the common stock and LLC membership units, accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events. The Company has adopted the provisions of ASU 2016-01 and values the investment using the measurement alternative, defined as cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. Research and Development The Company focuses on quality control and development of new products and the improvement of existing products. All cost related to research and development activities are expensed as incurred. During the nine months ended September 30, 2021, research and development cost totaled $1,096,333. Earnings (loss) per shares The Company presents both basic and diluted net income (loss) per share on the face of the consolidated statements of operations. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, and using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The only potentially dilutive securities outstanding during the periods presented were the convertible debt, options and warrants. The following table illustrates the computation of basic and diluted earnings per share (“EPS”) for the three and nine months ended September 30, 2021 and 2020: For the Three Months Ended September 30, 2021 For the Three Months Ended September 30, 2020 Net Income Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net income (loss) $ 2,481,592 166,964,408 $ 0.01 $ (1,399,862) 131,934,084 $ (0.01) Effect of Dilutive Securities Stock options and warrants - 1,663,499 - - - - Dilute EPS Net income (loss) plus assumed conversions $ 2,481,592 168,627,907 $ 0.01 $ (1,399,862) 131,934,084 $ (0.01) For the Nine Months Ended September 30, 2021 For the Nine Months Ended September 30, 2020 Net loss Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net loss $ (6,775,153) 161,118,324 $ (0.04) $ (3,712,388) 130,111,673 $ (0.03) Effect of Dilutive Securities Convertible debt - - - (1,557,294) 8,126,877 (0.01) Dilute EPS Net loss plus assumed conversions $ (6,775,153) 161,118,324 $ (0.04) $ (5,269,682) 138,238,550 $ (0.04)

Note 3 - Leases

Note 3 - Leases	9 Months Ended
	Sep. 30, 2021
Notes
Note 3 - Leases	Note 3 – Leases The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company must discount lease payments based on an estimate of its incremental borrowing rate. As of September 30, 2021, the future minimum finance and operating lease payments were as follows: Finance Operating Twelve Months Ending September 30 , Leases Leases 2022 $ 1,895,925 $ 175,319 2023 1,923,246 104,648 2024 1,946,100 106,680 2025 1,911,278 53,848 2026 1,859,102 - Thereafter 17,239,539 - Total payments 26,775,190 440,495 Less: imputed interest (10,656,923) (85,606) Total obligation 16,118,267 354,889 Less: current portion (628,574) (135,207) Non-current financing leases obligations $ 15,489,693 $ 219,682 As of October 1, 2020, the American Precision Fabricators, Inc. (“APF”) building lease with Harbor Island Properties, LLC was modified, assignment was transferred to Excel Fabrication, LLC (“Excel”), and Quality Circuit Assembly, Inc. (“QCA”). As part of the modification, the lease was extended through 2037 and the payment terms were amended effective January 15, 2021. As a result of this amendment, the Company remeasured the finance lease liability and recorded an additional $279,287 to the related asset and finance lease liability on the date of the modification. Operating Leases The table below presents the lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of September 30, 2021, and December 31, 2020: September 30, December 31, Classification on Balance Sheet 2021 2020 Assets Operating lease assets Operating lease right of use assets $ 347,712 $ 581,311 Total lease assets $ 347,712 $ 581,311 Liabilities Current liabilities Operating lease liability Current operating lease liability $ 135,207 $ 334,500 Noncurrent liabilities Operating lease liability Long-term operating lease liability 219,682 269,030 Total lease liability $ 354,889 $ 603,530 On May 3, 2021, the Company entered into a lease agreement for the building on 4740 Cleveland in Ft. Myers, Fl. The lease has a term of 72 months with monthly payments ranging from $40,833 to $49,583 from May 2021-July 2021 and $58,333 from August 2021 through the end of the term. The Company determined the lease to be an operating lease and recognized a right-of-use asset and operating lease liability of $3,689,634 based on the present value of the minimum lease payments discounted using an incremental borrowing rate of 3.96%. This lease was terminated on August 27, 2021, when the Company purchased the building. At September 30, 2021 and December 31, 2020, the weighted average remaining lease terms were 2.88 and 2.98 years; respectively, and the weighted average discount rates were 15% and 15%, respectively.

Note 4 - Notes Payable and Line

Note 4 - Notes Payable and Line of Credit	9 Months Ended
	Sep. 30, 2021
Notes
Note 4 - Notes Payable and Line of Credit	Note 4 – Notes Payable and Line of Credit The outstanding balances for the loans as of September 30, 2021, and December 31, 2020, were as follows: September 30, December 31, 2021 2020 Lines of credit, current portion $ 3,718,972 $ 2,819,793 Equipment loans, current portion 63,531 245,388 PPP loans 278,867 - Term notes, current portion 5,468,843 4,035,730 Total current 9,530,213 7,100,911 PPP/EIDL loans 877,083 4,340,956 Long-term portion of equipment loans and term notes 6,645,379 10,860,494 Total notes payable and line of Credit $ 17,052,675 $ 22,302,361 Future scheduled maturities of outstanding notes payable are as follows: Twelve Months Ending September 30, 2022 $ 9,530,212 2023 933,846 2024 2,183,157 2025 125,699 2026 130,755 Thereafter 4,149,006 Total $ 17,052,675 During the nine months ended September 30, 2021, the Company received forgiveness on nine loans under the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. The Company recognized a gain on forgiveness of debt of $4,896,573. In connection with the Deluxe acquisition in November 2019, the Company issued two subordinated secured promissory notes to the seller. The first note for $1,900,000 bears interest at 4.25% per annum, require monthly payment for the first 35 months of $19,463 with any remaining principal and accrued interest due on the 3 year-anniversary. The second note for $496,343 bore interest at 8.75% matured in January 2020 and was fully settled through a debt conversion agreement with the seller. On April 8, 2021, the Company entered into a settlement agreement with the seller wherein the outstanding balance on the first note amounting to $1,883,418 including accrued interest and net other costs was settled in full through a payment of approximately $887,000 and the exchange of 1,617,067 shares of the Company’s Class C common shares held by the seller for the same number of shares of the Company’s Class A common stock. The Company recognized a gain on extinguishment of debt totaling $803,079 during the nine months ended September 30, 2021, as a result of the settlement of the note. In August 2020, the company filed a lawsuit against Alan Martin regarding his note payable (See Note 11). As of September 30, 2021, the note had a balance of $2,857,500 and accrued interest of $1,091,212 which is reflective in the current liabilities. During 2021, the Company entered into three revolving lines of credit totaling $8.3 million and two capital expenditures lines of credit totaling $1.0 million. The revolving lines of credit used as of September 30, 2021, totaled $3.7 million with an interest rate ranging from prime plus 2.50% - 4.25% and a term of one year. As of September 30, 2021, the Company had $5.6 in additional funds available to borrow. On August 27, 2021 the Company entered into $4.7 million agreement for the purchase of a building located at 4740 Cleveland in Ft. Myers, Florida. The loan bears interest at a rate of 3.95% per annum for a term of 10 years and requires monthly payments of $24,574. The loan is secured by the building and a guarantee by the Company. As of September 30, 2021, there were no payments made for this loan as the initial payment was due in October 2021, and subsequent payments are due by the 27 th

Note 5 - Notes Payable, Related

Note 5 - Notes Payable, Related Parties	9 Months Ended
	Sep. 30, 2021
Notes
Note 5 - Notes Payable, Related Parties	Note 5 – Notes Payable, Related Parties At September 30, 2021, and December 31, 2020, notes payable due to related parties consisted of the following: September 30, December 31, 2021 2020 Notes payable; non-interest bearing; due upon demand; unsecured $ 3,000 $ 3,000 Series of notes payable, bearing interest at rates from 0% to 20% per annum, with maturity dates from April 2018 to July 2021, unsecured - 235,651 Total notes payable - related parties $ 3,000 $ 238,651 Two non-interest-bearing notes totaling $3,000 were in default as of September 30, 2021. These notes were due on demand by the lenders as of the date of this Report.

Note 6 - Convertible Notes Paya

Note 6 - Convertible Notes Payable	9 Months Ended
	Sep. 30, 2021
Notes
Note 6 - Convertible Notes Payable	Note 6 – Convertible Notes Payable At September 30, 2021, and December 31, 2020, convertible notes payable consisted of the following: September 30, December 31, 2021 2020 Series of convertible notes payable issued prior to December 31, 2016, bearing interest at rates of 8% - 10% per annum, with due dates ranging from December 2016 through June 2017. The outstanding principal and interest balances are convertible into shares of Class A common stock at the option of the debt holder at exercise price of $1 per share. $ 7,500 $ 25,000 Secured convertible notes payable issued to the sellers of QCA on April 1, 2016 for an aggregate of $2,000,000, bearing interest at 5% per annum, due in monthly payments starting on July 1, 2016 and due in full on July 1, 2019. On August 6 and 11, 2019, the Company extended the due date of the two notes to December 31, 2020 and December 31, 2022, respectively. In May and June 2020, these convertible notes were amended — see (A) below. The outstanding principal and interest balances were fully paid during the nine months ended September 30, 2021. - 1,291,463 On December 7, 2018, the Company entered into a variable convertible note for $130,000 with net proceeds of $122,200. The note is due September 7, 2019 and bears interest at 12% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a discount of 40% to the lowest trading closing prices of the stock for 20 days prior to conversion. This note was amended in November 2019 to increase the principal amount by $180,000 due to penalty interest; increase the interest rate to 15% and effect a floor in the conversion price of $0.15 per share. The outstanding principal and interest balance of the note was converted during the nine months ended September 30, 2021. - 7,538 On November 14, 2019, the Company issued a convertible note for $200,000. The note is due November 13, 2020 and bears interest at 15% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a fixed price of $0.15 per share. The outstanding principal balance of the note was converted during the nine months ended September 30, 2021. - 200,000 In December 2020 and January 2021, the Company issued convertible notes to individual investors totaling to $1,890,500. The notes are due three to six months from the date of issuance; accrue interest at 5 – 6.25% per annum and are convertible into shares of the Company's Class A common stock at a fixed rate of $0.25 to $3.00. The outstanding principal balance of the notes were converted during the nine months ended September 30, 2021. - 1,482,500 Total convertible notes payable 7,500 3,006,501 Less: discount on convertible notes payable - (1,343,624) Total convertible notes payable, net of discount 7,500 1,662,877 Less: current portion of convertible notes payable (7,500) (562,242) Long-term portion of convertible notes payable $ - $ 1,100,635 In May and June 2020 the Company amended the following seller notes: - - A loss on extinguishment of debt of $192,272 was recognized on these transactions in June 2020. During the nine months ended September 30, 2021, and the year ended December 31, 2020, the Company issued convertible notes with fixed conversion prices. The Company recognized a beneficial conversion feature related to these convertible notes amounting to $92,428 and $1,482,500 for the nine months ended September 30, 2021, and the year ended December 31, 2020, respectively, as a debt discount to the convertible notes and as a component of equity. The discounts are being amortized over the terms of the convertible notes payable. Amortization of debt discounts during the nine months ended September 30, 2021 and 2020, amounted to $1,436,052 and $507,534, respectively, and is recorded as interest expense in the accompanying consolidated statements of operations. There was no remaining unamortized discount balance for these notes as of September 30, 2021. A summary of the activity in the Company's convertible notes payable is provided below: Balance outstanding, December 31, 2020 $ 1,662,877 Issuance of convertible notes payable for cash 408,000 Repayment of notes (1,680,964) Conversion of notes payable to common stock (1,726,037) Amortization of debt discounts 1,436,052 Discount from beneficial conversion feature (92,428) Balance outstanding, September 30, 2021 $ 7,500

Note 7 - Stockholders' Equity

Note 7 - Stockholders' Equity	9 Months Ended
	Sep. 30, 2021
Notes
Note 7 - Stockholders' Equity	Note 7 – Stockholders' Equity Common Stock The Company had the following transactions in its common stock during the nine months ended September 30, 2021: · · · · · · · · Preferred Stock · · Stock Options The following summarizes the stock option activity for the nine months ended September 30, 2021: Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Life (Years) Value Outstanding at December 31, 2020 1,790,000 $ 0.19 7.09 $ 6,176,855 Granted - Forfeited - Exercised - Outstanding at September 30, 2021 1,790,000 $ 0.19 6.34 $ 3,599,255 Vested and expected to vest at September 30, 2021 1,790,000 $ 0.19 6.34 $ 3,599,255 Exercisable at September 30, 2021 1,556,126 $ 0.21 6.27 $ 3,097,221 The following table summarizes information about options outstanding and exercisable as of September 30, 2021: Options Outstanding Options Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price 0.05 979,000 6.88 0.05 761,063 0.05 0.10 85,000 6.53 0.10 69,063 0.10 0.13 388,500 5.84 0.13 388,500 0.13 0.26 114,000 5.59 0.26 114,000 0.26 0.90 223,500 5.52 0.90 223,500 0.90 1,790,000 1,556,126 During the nine months ended September 30, 2021 and 2020, stock option expense amounted to $31,933 and $58,887, respectively. Unrecognized stock option expense as of September 30, 2021, amounted to $11,815, which will be recognized over a period extending through December 2022. Warrants The following summarizes the warrants activity for the nine months ended September 30, 2021: Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Warrants Price Life (Years) Value Outstanding at December 31, 2020 275,000 $ 1.01 0.23 $ 723,250 Granted 416,667 6.60 Forfeited (275,000) 1.01 Exercised - Outstanding at September 30, 2021 416,667 $ 6.60 3.39 $ - Vested and expected to vest at September 30, 2021 416,667 $ 6.60 3.39 $ - Exercisable at September 30, 2021 - $ - - $ - The following table summarizes information about warrants outstanding and exercisable as of September 30, 2021: Warrants Outstanding Warrants Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price $ 6.60 416,667 3.39 $ 6.60 - $ - 416,667 - During the nine months ended September 30, 2021, the Company issued 416,667 warrants to a placement agent in connection with sale of its common stock. The warrants have an exercise price of $6.60, are exercisable as of August 16, 2021 and expire on February 16, 2025. The fair value of the 416,667 warrants, issued to the placement agent during the nine months ended September 30, 2021, of $2,498,637 was determined using the Black-Scholes option pricing model with the following assumptions: Stock price $6.00 Risk-free interest rate 0.01% Expected life of the options 4 years Expected volatility 347% Expected dividend yield 0% The fair value of the warrants was recorded as offering costs with a corresponding credit to additional paid in capital.

Note 8 - Business Combination

Note 8 - Business Combination	9 Months Ended
	Sep. 30, 2021
Notes
Note 8 - Business Combination	Note 8 – Business Combinations Vayu (US) Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”). Under the provision of ASC 805, the Company had to determine whether this acquisition was a business combination or an asset (or a group of assets) acquisition. In doing so, the Company determined that the acquisition of Vayu was in fact an asset purchase. Of the consideration given for the Vayu acquisition more than 95% was concentrated in a single asset or a group of assets in Intellectual Property. As such, the Company accounted for this acquisition as an asset acquisition in accordance with ASC 805-10-20. Accordingly, the assets acquired are initially recognized at the consideration paid, which was the fair value of the series D preferred stock issued, including direct acquisition costs, of which there were none. The cost is allocated to the group of assets acquired based on their relative fair values. The assets acquired and liabilities assumed were as follows at the acquisition date: Purchase Allocation Cash $ 81,442 Property and equipment 50,000 Intellectual property 6,981,256 Non-solicitation covenant 90,000 Accrued expenses and other current liabilities (411,539) SBA loan (PPP funds) (137,850) $ 6,653,309 The purchase price was paid as follows: Series D Preferred Stock $ 6,653,309 $ 6,653,309 TDI On May 5, 2021, the Company closed on the acquisition of Thermal Dynamics, Inc., a Delaware corporation. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date. Purchase Allocation Accounts receivable $ 1,408,682 Contract assets 826,231 Property and equipment 111,789 Intangible assets 4,820,000 Goodwill 3,528,621 Accounts payable (786,151) Accrued expenses and other current liabilities (53,857) Contract liability (2,334,188) Notes payable (64,733) $ 7,456,394 The purchase price was paid as follows: Class A Common Stock $ 1,102,394 Cash 6,354,000 $ 7,456,394 Alt Labs On May 10, 2021, the Company closed on the acquisition of Alternative Laboratories, LLC., a Delaware limited liability company. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date. Purchase Allocation Accounts receivable $ 397,441 Inventory 2,621,653 Property and equipment 1,739,441 Intangible assets 10,410,000 Goodwill 252,851 Other asset 390,502 Accounts payable (397,441) Accrued expenses and other current liabilities (62,242) Contract liability (1,754,290) Noted payable (1,695,238) $ 11,902,677 The purchase price was paid as follows: Class A Common Stock $ 1,432,677 Cash 10,470,000 $ 11,902,677 On May 4, 2021, the Company also entered into an agreement to acquire the 100% membership interest in 4740 Cleveland LLC (“Cleveland”), a Florida limited liability company that is the owner of the building currently being leased by Alt Labs, for a total purchase price of $7,000,000. In connection with this agreement, the Company placed in escrow the amount of $1,400,000 which will be applied to the purchase price upon closing. The Company closed on the purchase of the building in August 2021. The following are the unaudited pro forma results of operations for the nine months ended September 30, 2021 and 2020, as if Excel, Impossible Aerospace, Inc. (“IA”), Vayu, TDI, and Alt Labs had been acquired on January 1, 2020. The pro forma results include estimates and assumptions which management believes are reasonable. However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of these entities, and are not necessarily indicative of the results that would have occurred if the business combination had been in effect on the dates indicated. Pro Forma Combined Financials (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Sales $ 17,398,316 $ 16,299,024 $ 49,465,682 $ 51,377,078 Cost of goods sold 12,104,134 12,020,468 35,183,907 37,090,187 Gross profit 5,294,182 4,278,556 14,281,775 14,286,891 Operating expenses 6,966,642 4,855,978 21,474,825 17,294,094 Loss from operations (1,672,460) (577,422) (7,193,050) (3,007,203) Net income (loss) 2,481,592 (809,618) (3,892,897) (2,742,963) Net income (loss) per share 0.01 (0.01) (0.02) (0.02)

Note 9 - Equity Investments

Note 9 - Equity Investments	9 Months Ended
	Sep. 30, 2021
Notes
Note 9 - Equity Investments	Note 9 – Equity Investments AmplifeiIntl LLC On September 15, 2021, A4 Manufacturing, Inc. entered into a Membership Interest Purchase Agreement acquiring approximately a 9% membership interest in AmplifeiIntl LLC (also doing business as Happinss), a Texas limited liability company. The membership interest is non-voting and the Company does not have the ability to exercise significant influence over operating and financial activities. The equity investment is being valued using cost as there is no market for the membership units, and accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events. As of September 30, 2021, the Company determined there was no impairment. The membership interest was paid for as follows: Accounts receivable converted $ 1,000,000 Cash 350,000 Total $ 1,350,000

Note 10 - Segment Reporting

Note 10 - Segment Reporting	9 Months Ended
	Sep. 30, 2021
Notes
Note 10 - Segment Reporting	Note 10 – Segment Reporting The Company discloses segment information that is consistent with the way in which management operates and views its business. Effective during the quarter ended September 30, 2021, the Company has reduced its reportable segments to four operating segments as represented by the Company’s four silos: A4 Construction Services, Inc.; A4 Manufacturing, Inc.; A4 Aerospace Corporation; and A4 Defense Systems, Inc. The Company’s reportable segments for the three and nine months ended September 30, 2021, and September 30, 2020, and as of September 30, 2021 and December 31, 2020: Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue Construction Services $ 5,465,881 $ 5,488,718 $ 15,565,332 $ 17,198,134 Manufacturing 10,210,549 3,240,915 21,506,262 9,409,959 Defense 1,721,886 - 2,866,991 - $ 17,398,316 $ 8,729,633 $ 39,938,585 $ 26,608,093 Gross profit Construction Services $ 678,702 $ 343,965 $ 1,392,904 $ 2,753,554 Manufacturing 3,128,290 995,262 6,672,549 2,301,433 Defense 641,144 - 1,101,362 - $ 4,448,136 $ 1,339,227 $ 9,166,815 $ 5,054,987 Income (loss) from operations Construction Services $ (607,794) $ (529,896) $ (3,464,327) $ (195,470) Manufacturing 947,792 392,029 1,679,930 (886,867) Aerospace (963,134) - (3,886,311) - Defense (135,575) - (131,953) - Unallocated (913,749) (434,184) (3,846,085) (2,199,556) $ (1,672,460) $ (572,051) $ (9,648,746) $ (3,281,893) Depreciation and amortization Construction Services $ 240,966 $ 389,269 $ 995,014 $ 1,099,834 Manufacturing 469,419 153,271 1,049,042 455,714 Aerospace 222,291 - 448,659 - Defense 87,322 - 143,539 - Unallocated 158,807 10,520 215,715 27,056 $ 1,178,805 $ 553,060 $ 2,851,969 $ 1,582,604 Interest Expense Construction Services $ 150,028 $ 567,206 $ 832,498 $ 1,723,594 Manufacturing 113,910 233,283 382,785 615,436 Defense - - 825 - Unallocated 273,944 338,973 2,010,084 1,355,501 $ 537,882 $ 1,139,462 $ 3,226,192 $ 3,694,531 Net income (loss) Construction Services $ 1,792,912 $ (1,027,073) $ (881,293) $ (1,240,693) Manufacturing 2,913,757 400,368 3,371,416 (1,145,527) Aerospace (963,134) - (3,456,780) - Defense (120,481) - (114,097) - Unallocated (1,141,462) (773,157) (5,694,399) (1,326,168) $ 2,481,592 $ (1,399,862) $ (6,775,153) $ (3,712,388) As of September 30, 2021 As of December 31, 2020 Total Assets Construction Services $ 16,681,507 $ 22,648,181 Manufacturing 43,804,926 10,731,936 Aerospace 14,332,809 6,342,863 Defense 11,319,049 - Unallocated 10,973,041 1,011,203 $ 97,111,332 $ 40,734,183 Goodwill Construction Services $ 121,221 $ 121,221 Manufacturing 2,216,612 1,963,761 Defense 3,528,621 - $ 5,866,454 $ 2,084,982 Accounts receivable, net Construction Services $ 4,793,691 $ 4,501,401 Manufacturing 7,205,449 1,983,468 Defense 991,089 - $ 12,990,229 $ 6,484,869

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Notes
Note 11 - Commitments and Contingencies	Note 11 – Commitments and Contingencies Legal Proceedings From time to time, the Company may become involved in lawsuits and other legal proceedings that arise in the course of business. Litigation is subject to inherent uncertainties, and it is not possible to predict the outcome of litigation with total confidence. As of the date of this Report, the Company was not aware of any legal proceedings or potential claims against it whose outcome would be likely, individually or in the aggregate, to have a material adverse effect on the Company’s business, financial condition, operating results, or cash flows, except as set forth below. In June 2020, the Company’s subsidiary Excel Fabrication, LLC filed a lawsuit against Fusion Mechanical, LLC, in the Fifth Judicial District Court, State of Idaho (Case Number CV42-20-2246). The Company claimed tortious interference and trade secret violations by the defendant. The defendant filed a motion to dismiss, which was denied by the Court. The defendant filed a second motion to dismiss and the Company filed a memorandum in response to the second motion to dismiss, for which a hearing was held on May 10, 2021. On June 11, 2021, the court issued a decision narrowing the claims of the plaintiffs to three items, breach of contract, good faith and fair dealings, and intentional interference for economic advantage. These were the Company’s three main points of contention. As of the date of this Report, discovery was proceeding. The Company intends to pursue vigorously its claims. In August 2020, the Company filed a lawsuit, in the United States District Court, District of Arizona (Case No.2:20-cv-01679-DJH), against Alan Martin, the seller of Horizon Well Testing LLC (“HWT”) dba Venture West Energy Services, LLC. The Company brought claims for breach of contract, including but not limited to breaches of the seller’s representations and warranties in the purchase agreement in connection with the acquisition of HWT. The defendant answered and counterclaimed, claiming breach by the Company of its obligation to issue a promissory note (to be issued in connection with the acquisition of HWT). The parties have engaged in discovery and settlement negotiations, both of which were ongoing as of the date of this Report. Additionally, a settlement conference is scheduled for November 18, 2021. In May 2021, the Company and several shareholders filed a lawsuit, in the United States District Court for the District of Arizona (Case number 2:21-cv-00886-MTL) against Fin Capital LLC ("Fin Cap"), and Grizzly Research LLC ("Grizzly") alleging securities fraud, tortious interference with business expectancy and libel and slander for disseminating false and misleading statements about Alpine 4 and its employees to manipulate the stock price and further their own financial interests.

Note 12 - Subsequent Events

Note 12 - Subsequent Events	9 Months Ended
	Sep. 30, 2021
Notes
Note 12 - Subsequent Events	Note 12 – Subsequent Events On November 1, 2021, the Company issued 2,506,249 shares of Class A common stock for no additional consideration upon conversion of 1,652,591 shares of Series C Preferred Stock and 1,432,244 shares of Series D Preferred Stock into Class A Common Stock, pursuant to the respective Certificates of Designation of the Series C and Series D Preferred Stock. Identified Technologies Corporation On October 20, 2021, the Company and the Company’s subsidiary, A4 Aerospace, Inc., a Delaware corporation (the “Buyer”), entered into a Stock Purchase Agreement (the “SPA”) with Identified Technologies Corporation, a Delaware corporation with foreign registration in Pennsylvania (the “Target”), and all of the shareholders of the Target: Birchmere Ventures 5 LP; Xalisco Ventures; Richard Zhang; Ashok Trivedi; Sunil Wadhwani; Innovation Works, Inc.; Startbot LLC; 2008 Mark Zappala IRR Trust; Birchmere Labs I LP; Cimax Partners I; Wu-Yang Family Trust; Zappala Family LP; and AT Gekko PR (each a “Shareholder” and collectively, the “Shareholders”). Pursuant to the SPA, the Buyer purchased all of the outstanding shares of capital stock of the Target, a total of 6,486,044 shares of the Target’s capital stock (the “Target Shares”). The total purchase price for the Target Shares was $4,000,000 and was paid in shares of the Company’s Class A common stock (the “Company Shares”), issued to the Shareholders. Following the closing of the transaction, the Buyer owned 100% of the capital stock of the Target. The acquisition of the Target closed on October 20, 2021. A total of 888,881 shares of restricted Class A common stock with a fair value of approximately $3.6 million were issued to the 13 Shareholders, together with an aggregate of $35.47 in cash (to avoid the issuance of fractional shares). Pursuant to the SPA, the Shareholders were limited to being able to sell 33% of their shares every 90 days once the Shares were no longer restricted pursuant to Rule 144.

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Principles of Consolidation	Principles of consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of September 30, 2021 and December 31, 2020. Significant intercompany balances and transactions have been eliminated.

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies: Use of Estimates, Policy (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Use of Estimates, Policy	Use of estimates The consolidated financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. In many instances, the Company could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of long-lived assets, valuation allowance for deferred tax assets and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2021 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2021 and beyond. COVID-19 did have a negative impact on the Company’s financial performance in 2020. During the nine months ended September 30, 2021, there was no impairment charge related to intangible assets and goodwill.

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Cash and Restricted Cash	Cash and Restricted Cash Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of September 30, 2021, and December 31, 2020, the Company had no cash equivalents. As of September 30, 2021, and December 31, 2020, the Company had $0 and $444,845 in restricted cash, respectively, for amounts held in escrow. The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows. September 30, December 31, 2021 2020 Cash $ 5,425,913 $ 277,738 Restricted cash - 444,845 Total cash and restricted cash shown in statement of cash flows $ 5,425,913 $ 722,583

Note 2 - Summary of Significa_5

Note 2 - Summary of Significant Accounting Policies: Major Customers (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Major Customers	Major Customers The Company had two customers that made up 16% and 18%, respectively, of accounts receivable as of September 30, 2021. The Company had two customers that made up 10% and 8%, respectively, of accounts receivable as of December 31, 2020. For the nine months ended September 30, 2021 and 2020, the Company had one customer that made up 13% and 10% of total revenues, respectively.

Note 2 - Summary of Significa_6

Note 2 - Summary of Significant Accounting Policies: Fair Value Measurement (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Fair Value Measurement	Fair value measurements Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 Level 2 Level 3 The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates. As of September 30, 2021 and December 31, 2020, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis.

Note 2 - Summary of Significa_7

Note 2 - Summary of Significant Accounting Policies: Equity Investments (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Equity Investments	Equity Investments The Company’s equity investments consist of investment in one private company in which the Company does not have the ability to exercise significant influence over their operating and financial activities. This investment is carried at cost as there is no market for the common stock and LLC membership units, accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events. The Company has adopted the provisions of ASU 2016-01 and values the investment using the measurement alternative, defined as cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

Note 2 - Summary of Significa_8

Note 2 - Summary of Significant Accounting Policies: Research and Development (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Research and Development	Research and Development The Company focuses on quality control and development of new products and the improvement of existing products. All cost related to research and development activities are expensed as incurred. During the nine months ended September 30, 2021, research and development cost totaled $1,096,333.

Note 2 - Summary of Significa_9

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share (Policies)	9 Months Ended
	Sep. 30, 2021
Policies
Earnings (loss) per share	Earnings (loss) per shares The Company presents both basic and diluted net income (loss) per share on the face of the consolidated statements of operations. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, and using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The only potentially dilutive securities outstanding during the periods presented were the convertible debt, options and warrants. The following table illustrates the computation of basic and diluted earnings per share (“EPS”) for the three and nine months ended September 30, 2021 and 2020: For the Three Months Ended September 30, 2021 For the Three Months Ended September 30, 2020 Net Income Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net income (loss) $ 2,481,592 166,964,408 $ 0.01 $ (1,399,862) 131,934,084 $ (0.01) Effect of Dilutive Securities Stock options and warrants - 1,663,499 - - - - Dilute EPS Net income (loss) plus assumed conversions $ 2,481,592 168,627,907 $ 0.01 $ (1,399,862) 131,934,084 $ (0.01) For the Nine Months Ended September 30, 2021 For the Nine Months Ended September 30, 2020 Net loss Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net loss $ (6,775,153) 161,118,324 $ (0.04) $ (3,712,388) 130,111,673 $ (0.03) Effect of Dilutive Securities Convertible debt - - - (1,557,294) 8,126,877 (0.01) Dilute EPS Net loss plus assumed conversions $ (6,775,153) 161,118,324 $ (0.04) $ (5,269,682) 138,238,550 $ (0.04)

Note 2 - Summary of Signific_10

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash: Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table	September 30, December 31, 2021 2020 Cash $ 5,425,913 $ 277,738 Restricted cash - 444,845 Total cash and restricted cash shown in statement of cash flows $ 5,425,913 $ 722,583

Note 2 - Summary of Signific_11

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share: Schedule of Earnings Per Share, Basic and Diluted (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	For the Three Months Ended September 30, 2021 For the Three Months Ended September 30, 2020 Net Income Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net income (loss) $ 2,481,592 166,964,408 $ 0.01 $ (1,399,862) 131,934,084 $ (0.01) Effect of Dilutive Securities Stock options and warrants - 1,663,499 - - - - Dilute EPS Net income (loss) plus assumed conversions $ 2,481,592 168,627,907 $ 0.01 $ (1,399,862) 131,934,084 $ (0.01) For the Nine Months Ended September 30, 2021 For the Nine Months Ended September 30, 2020 Net loss Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net loss $ (6,775,153) 161,118,324 $ (0.04) $ (3,712,388) 130,111,673 $ (0.03) Effect of Dilutive Securities Convertible debt - - - (1,557,294) 8,126,877 (0.01) Dilute EPS Net loss plus assumed conversions $ (6,775,153) 161,118,324 $ (0.04) $ (5,269,682) 138,238,550 $ (0.04)

Note 3 - Leases_ Schedule of Fu

Note 3 - Leases: Schedule of Future Minimum Lease Payments for Capital Leases (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Future Minimum Lease Payments for Capital Leases	Finance Operating Twelve Months Ending September 30 , Leases Leases 2022 $ 1,895,925 $ 175,319 2023 1,923,246 104,648 2024 1,946,100 106,680 2025 1,911,278 53,848 2026 1,859,102 - Thereafter 17,239,539 - Total payments 26,775,190 440,495 Less: imputed interest (10,656,923) (85,606) Total obligation 16,118,267 354,889 Less: current portion (628,574) (135,207) Non-current financing leases obligations $ 15,489,693 $ 219,682

Note 3 - Leases_ Schedule of Ri

Note 3 - Leases: Schedule of Right of Use Assets and Lease Liabilities (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Right of Use Assets and Lease Liabilities	September 30, December 31, Classification on Balance Sheet 2021 2020 Assets Operating lease assets Operating lease right of use assets $ 347,712 $ 581,311 Total lease assets $ 347,712 $ 581,311 Liabilities Current liabilities Operating lease liability Current operating lease liability $ 135,207 $ 334,500 Noncurrent liabilities Operating lease liability Long-term operating lease liability 219,682 269,030 Total lease liability $ 354,889 $ 603,530

Note 4 - Notes Payable and Li_2

Note 4 - Notes Payable and Line of Credit: Schedule of Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Notes Payable	September 30, December 31, 2021 2020 Lines of credit, current portion $ 3,718,972 $ 2,819,793 Equipment loans, current portion 63,531 245,388 PPP loans 278,867 - Term notes, current portion 5,468,843 4,035,730 Total current 9,530,213 7,100,911 PPP/EIDL loans 877,083 4,340,956 Long-term portion of equipment loans and term notes 6,645,379 10,860,494 Total notes payable and line of Credit $ 17,052,675 $ 22,302,361

Note 4 - Notes Payable and Li_3

Note 4 - Notes Payable and Line of Credit: Future Scheduled Maturities Of Outstanding Notes Payable To Third Parties (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Future Scheduled Maturities Of Outstanding Notes Payable To Third Parties	Twelve Months Ending September 30, 2022 $ 9,530,212 2023 933,846 2024 2,183,157 2025 125,699 2026 130,755 Thereafter 4,149,006 Total $ 17,052,675

Note 5 - Notes Payable, Relat_2

Note 5 - Notes Payable, Related Parties: Schedule of Notes Payable, Related Parties (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Notes Payable, Related Parties	September 30, December 31, 2021 2020 Notes payable; non-interest bearing; due upon demand; unsecured $ 3,000 $ 3,000 Series of notes payable, bearing interest at rates from 0% to 20% per annum, with maturity dates from April 2018 to July 2021, unsecured - 235,651 Total notes payable - related parties $ 3,000 $ 238,651

Note 6 - Convertible Notes Pa_2

Note 6 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Convertible Notes Payable	September 30, December 31, 2021 2020 Series of convertible notes payable issued prior to December 31, 2016, bearing interest at rates of 8% - 10% per annum, with due dates ranging from December 2016 through June 2017. The outstanding principal and interest balances are convertible into shares of Class A common stock at the option of the debt holder at exercise price of $1 per share. $ 7,500 $ 25,000 Secured convertible notes payable issued to the sellers of QCA on April 1, 2016 for an aggregate of $2,000,000, bearing interest at 5% per annum, due in monthly payments starting on July 1, 2016 and due in full on July 1, 2019. On August 6 and 11, 2019, the Company extended the due date of the two notes to December 31, 2020 and December 31, 2022, respectively. In May and June 2020, these convertible notes were amended — see (A) below. The outstanding principal and interest balances were fully paid during the nine months ended September 30, 2021. - 1,291,463 On December 7, 2018, the Company entered into a variable convertible note for $130,000 with net proceeds of $122,200. The note is due September 7, 2019 and bears interest at 12% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a discount of 40% to the lowest trading closing prices of the stock for 20 days prior to conversion. This note was amended in November 2019 to increase the principal amount by $180,000 due to penalty interest; increase the interest rate to 15% and effect a floor in the conversion price of $0.15 per share. The outstanding principal and interest balance of the note was converted during the nine months ended September 30, 2021. - 7,538 On November 14, 2019, the Company issued a convertible note for $200,000. The note is due November 13, 2020 and bears interest at 15% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a fixed price of $0.15 per share. The outstanding principal balance of the note was converted during the nine months ended September 30, 2021. - 200,000 In December 2020 and January 2021, the Company issued convertible notes to individual investors totaling to $1,890,500. The notes are due three to six months from the date of issuance; accrue interest at 5 – 6.25% per annum and are convertible into shares of the Company's Class A common stock at a fixed rate of $0.25 to $3.00. The outstanding principal balance of the notes were converted during the nine months ended September 30, 2021. - 1,482,500 Total convertible notes payable 7,500 3,006,501 Less: discount on convertible notes payable - (1,343,624) Total convertible notes payable, net of discount 7,500 1,662,877 Less: current portion of convertible notes payable (7,500) (562,242) Long-term portion of convertible notes payable $ - $ 1,100,635

Note 6 - Convertible Notes Pa_3

Note 6 - Convertible Notes Payable: Schedule of Acitivity of Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Acitivity of Convertible Notes Payable	Balance outstanding, December 31, 2020 $ 1,662,877 Issuance of convertible notes payable for cash 408,000 Repayment of notes (1,680,964) Conversion of notes payable to common stock (1,726,037) Amortization of debt discounts 1,436,052 Discount from beneficial conversion feature (92,428) Balance outstanding, September 30, 2021 $ 7,500

Note 7 - Stockholders' Equity_

Note 7 - Stockholders' Equity: Schedule of Common Stock Outstanding Roll Forward (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Common Stock Outstanding Roll Forward	Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Life (Years) Value Outstanding at December 31, 2020 1,790,000 $ 0.19 7.09 $ 6,176,855 Granted - Forfeited - Exercised - Outstanding at September 30, 2021 1,790,000 $ 0.19 6.34 $ 3,599,255 Vested and expected to vest at September 30, 2021 1,790,000 $ 0.19 6.34 $ 3,599,255 Exercisable at September 30, 2021 1,556,126 $ 0.21 6.27 $ 3,097,221 The following table summarizes information about options outstanding and exercisable as of September 30, 2021: Options Outstanding Options Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price 0.05 979,000 6.88 0.05 761,063 0.05 0.10 85,000 6.53 0.10 69,063 0.10 0.13 388,500 5.84 0.13 388,500 0.13 0.26 114,000 5.59 0.26 114,000 0.26 0.90 223,500 5.52 0.90 223,500 0.90 1,790,000 1,556,126

Note 7 - Stockholders' Equity_2

Note 7 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Stockholders' Equity Note, Warrants or Rights	The following summarizes the warrants activity for the nine months ended September 30, 2021: Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Warrants Price Life (Years) Value Outstanding at December 31, 2020 275,000 $ 1.01 0.23 $ 723,250 Granted 416,667 6.60 Forfeited (275,000) 1.01 Exercised - Outstanding at September 30, 2021 416,667 $ 6.60 3.39 $ - Vested and expected to vest at September 30, 2021 416,667 $ 6.60 3.39 $ - Exercisable at September 30, 2021 - $ - - $ -

Note 7 - Stockholders' Equity_3

Note 7 - Stockholders' Equity: Schedule Of Summary Of Warrants Outstanding And Exercisable (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule Of Summary Of Warrants Outstanding And Exercisable	The following table summarizes information about warrants outstanding and exercisable as of September 30, 2021: Warrants Outstanding Warrants Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price $ 6.60 416,667 3.39 $ 6.60 - $ - 416,667 -

Note 7 - Stockholders' Equity_4

Note 7 - Stockholders' Equity: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair value of the 416,667 warrants, issued to the placement agent during the nine months ended September 30, 2021, of $2,498,637 was determined using the Black-Scholes option pricing model with the following assumptions: Stock price $6.00 Risk-free interest rate 0.01% Expected life of the options 4 years Expected volatility 347% Expected dividend yield 0%

Note 8 - Business Combination_

Note 8 - Business Combination: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Tables)	9 Months Ended
	Sep. 30, 2021
Vayu US
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Purchase Allocation Cash $ 81,442 Property and equipment 50,000 Intellectual property 6,981,256 Non-solicitation covenant 90,000 Accrued expenses and other current liabilities (411,539) SBA loan (PPP funds) (137,850) $ 6,653,309 The purchase price was paid as follows: Series D Preferred Stock $ 6,653,309 $ 6,653,309
TDI
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Purchase Allocation Accounts receivable $ 1,408,682 Contract assets 826,231 Property and equipment 111,789 Intangible assets 4,820,000 Goodwill 3,528,621 Accounts payable (786,151) Accrued expenses and other current liabilities (53,857) Contract liability (2,334,188) Notes payable (64,733) $ 7,456,394 The purchase price was paid as follows: Class A Common Stock $ 1,102,394 Cash 6,354,000 $ 7,456,394
Alt Labs
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Purchase Allocation Accounts receivable $ 397,441 Inventory 2,621,653 Property and equipment 1,739,441 Intangible assets 10,410,000 Goodwill 252,851 Other asset 390,502 Accounts payable (397,441) Accrued expenses and other current liabilities (62,242) Contract liability (1,754,290) Noted payable (1,695,238) $ 11,902,677 The purchase price was paid as follows: Class A Common Stock $ 1,432,677 Cash 10,470,000 $ 11,902,677

Note 8 - Business Combination_2

Note 8 - Business Combination: Business Acquisition, Pro Forma Information (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Business Acquisition, Pro Forma Information	Pro Forma Combined Financials (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Sales $ 17,398,316 $ 16,299,024 $ 49,465,682 $ 51,377,078 Cost of goods sold 12,104,134 12,020,468 35,183,907 37,090,187 Gross profit 5,294,182 4,278,556 14,281,775 14,286,891 Operating expenses 6,966,642 4,855,978 21,474,825 17,294,094 Loss from operations (1,672,460) (577,422) (7,193,050) (3,007,203) Net income (loss) 2,481,592 (809,618) (3,892,897) (2,742,963) Net income (loss) per share 0.01 (0.01) (0.02) (0.02)

Note 9 - Equity Investments_ Sc

Note 9 - Equity Investments: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Tables)	9 Months Ended
	Sep. 30, 2021
AmplifeiIntl LLC
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Accounts receivable converted $ 1,000,000 Cash 350,000 Total $ 1,350,000

Note 10 - Segment Reporting_ Sc

Note 10 - Segment Reporting: Schedule of Segment Reporting Information, by Segment (Tables)	9 Months Ended
	Sep. 30, 2021
Tables/Schedules
Schedule of Segment Reporting Information, by Segment	Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue Construction Services $ 5,465,881 $ 5,488,718 $ 15,565,332 $ 17,198,134 Manufacturing 10,210,549 3,240,915 21,506,262 9,409,959 Defense 1,721,886 - 2,866,991 - $ 17,398,316 $ 8,729,633 $ 39,938,585 $ 26,608,093 Gross profit Construction Services $ 678,702 $ 343,965 $ 1,392,904 $ 2,753,554 Manufacturing 3,128,290 995,262 6,672,549 2,301,433 Defense 641,144 - 1,101,362 - $ 4,448,136 $ 1,339,227 $ 9,166,815 $ 5,054,987 Income (loss) from operations Construction Services $ (607,794) $ (529,896) $ (3,464,327) $ (195,470) Manufacturing 947,792 392,029 1,679,930 (886,867) Aerospace (963,134) - (3,886,311) - Defense (135,575) - (131,953) - Unallocated (913,749) (434,184) (3,846,085) (2,199,556) $ (1,672,460) $ (572,051) $ (9,648,746) $ (3,281,893) Depreciation and amortization Construction Services $ 240,966 $ 389,269 $ 995,014 $ 1,099,834 Manufacturing 469,419 153,271 1,049,042 455,714 Aerospace 222,291 - 448,659 - Defense 87,322 - 143,539 - Unallocated 158,807 10,520 215,715 27,056 $ 1,178,805 $ 553,060 $ 2,851,969 $ 1,582,604 Interest Expense Construction Services $ 150,028 $ 567,206 $ 832,498 $ 1,723,594 Manufacturing 113,910 233,283 382,785 615,436 Defense - - 825 - Unallocated 273,944 338,973 2,010,084 1,355,501 $ 537,882 $ 1,139,462 $ 3,226,192 $ 3,694,531 Net income (loss) Construction Services $ 1,792,912 $ (1,027,073) $ (881,293) $ (1,240,693) Manufacturing 2,913,757 400,368 3,371,416 (1,145,527) Aerospace (963,134) - (3,456,780) - Defense (120,481) - (114,097) - Unallocated (1,141,462) (773,157) (5,694,399) (1,326,168) $ 2,481,592 $ (1,399,862) $ (6,775,153) $ (3,712,388) As of September 30, 2021 As of December 31, 2020 Total Assets Construction Services $ 16,681,507 $ 22,648,181 Manufacturing 43,804,926 10,731,936 Aerospace 14,332,809 6,342,863 Defense 11,319,049 - Unallocated 10,973,041 1,011,203 $ 97,111,332 $ 40,734,183 Goodwill Construction Services $ 121,221 $ 121,221 Manufacturing 2,216,612 1,963,761 Defense 3,528,621 - $ 5,866,454 $ 2,084,982 Accounts receivable, net Construction Services $ 4,793,691 $ 4,501,401 Manufacturing 7,205,449 1,983,468 Defense 991,089 - $ 12,990,229 $ 6,484,869

Note 2 - Summary of Signific_12

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash: Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Details
Cash	$ 5,425,913	$ 277,738
Restricted Cash	0	444,845
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 5,425,913	$ 722,583

Note 2 - Summary of Signific_13

Note 2 - Summary of Significant Accounting Policies: Major Customers (Details)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Accounts Receivable Concentration Risk
Concentration Risk, Customer	The Company had two customers that made up 16% and 18%, respectively, of accounts receivable	The Company had two customers that made up 10% and 8%, respectively, of accounts receivable
Revenues Concentration Risk
Concentration Risk, Customer	the Company had one customer that made up 13% and 10% of total revenues, respectively.

Note 2 - Summary of Signific_14

Note 2 - Summary of Significant Accounting Policies: Research and Development (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Research and development	$ 581,131	$ 0	$ 1,096,333	$ 0

Note 2 - Summary of Signific_15

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Net income (loss)	$ 2,481,592	$ (3,127,277)	$ (6,129,468)	$ (1,399,862)	$ (2,562,914)	$ 250,388	$ (6,775,153)	$ (3,712,388)
Weighted Average Number of Shares Outstanding, Basic	166,964,408			131,934,084			161,118,324	130,111,673
Earnings Per Share, Basic	$ 0.01			$ (0.01)			$ (0.04)	$ (0.03)
Dilutive Securities, Effect on Basic Earnings Per Share							$ 1,663,499	$ 8,126,877
Net Income (Loss) Attributable to Parent, Diluted	$ 2,481,592			$ (1,399,862)			$ (6,775,153)	$ (5,269,682)
Weighted Average Number of Shares Outstanding, Diluted	168,627,907			131,934,084			161,118,324	138,238,550
Earnings Per Share, Diluted	$ 0.01			$ (0.01)			$ (0.04)	$ (0.04)
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities								$ (1,557,294)
Dilutive Securities, per share								$ (0.01)

Note 3 - Leases_ Schedule of _2

Note 3 - Leases: Schedule of Future Minimum Lease Payments for Capital Leases (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Finance Lease, Liability, to be Paid, Year One	$ 1,895,925
Lessee, Operating Lease, Liability, to be Paid, Year One	175,319
Finance Lease, Liability, to be Paid, Year Two	1,923,246
Lessee, Operating Lease, Liability, to be Paid, Year Two	104,648
Finance Lease, Liability, to be Paid, Year Three	1,946,100
Lessee, Operating Lease, Liability, to be Paid, Year Three	106,680
Finance Lease, Liability, to be Paid, Year Four	1,911,278
Lessee, Operating Lease, Liability, to be Paid, Year Four	53,848
Finance Lease, Liability, to be Paid, Year Five	1,859,102
Lessee, Operating Lease, Liability, to be Paid, Year Five	0
Finance Lease, Liability, to be Paid, after Year Five	17,239,539
Lessee, Operating Lease, Liability, to be Paid, after Year Five	0
Finance Lease, Liability, Payment, Due	26,775,190
Lessee, Operating Lease, Liability, to be Paid	440,495
Finance Lease, Liability	16,118,267
Operating Lease, Liability	354,889	$ 603,530
Financing lease obligation, current portion	(628,574)	(639,527)
Operating lease obligation, current portion	(135,207)	(334,500)
Financing lease obligations, net of current portion	15,489,693	15,687,176
Operating lease obligations, net of current portion	219,682	$ 269,030
Finance Leases
Imputed Interest on Capital Lease	(10,656,923)
Operating Leases
Imputed Interest on Capital Lease	$ (85,606)

Note 3 - Leases (Details)

Note 3 - Leases (Details) - USD ($)	2 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Jul. 31, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Remeasurement of finance lease liability			$ 279,287	$ 0
Monthly Operating Lease Obligation	$ 58,333
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$ 3,689,634		$ 3,689,634
Operating Lease, Weighted Average Remaining Lease Term	2 years 10 months 17 days		2 years 10 months 17 days		2 years 11 months 23 days
Operating Lease, Weighted Average Discount Rate, Percent	15.00%		15.00%		15.00%
Minimum
Monthly Operating Lease Obligation		$ 40,833
Maximum
Monthly Operating Lease Obligation		$ 49,583

Note 3 - Leases_ Schedule of _3

Note 3 - Leases: Schedule of Right of Use Assets and Lease Liabilities (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Details
Right of use assets, net	$ 347,712	$ 581,311
Operating lease obligation, current portion	135,207	334,500
Operating lease obligations, net of current portion	219,682	269,030
Operating Lease, Liability	$ 354,889	$ 603,530

Note 4 - Notes Payable and Li_4

Note 4 - Notes Payable and Line of Credit: Schedule of Notes Payable (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Notes and Loans Payable, Current	$ 9,530,213	$ 7,100,911
Notes Payable	17,052,675	22,302,361
Lines of Credit
Notes and Loans Payable, Current	3,718,972	2,819,793
Equipment Loans
Notes and Loans Payable, Current	63,531	245,388
PPP/EIDL Loans
Notes and Loans Payable, Current	278,867	0
Long-term Debt	877,083	4,340,956
Short Term Notes
Notes and Loans Payable, Current	5,468,843	4,035,730
Equipment, Noncurrent
Long-term Debt	$ 6,645,379	$ 10,860,494

Note 4 - Notes Payable and Li_5

Note 4 - Notes Payable and Line of Credit: Future Scheduled Maturities Of Outstanding Notes Payable To Third Parties (Details)	9 Months Ended
	Sep. 30, 2021USD ($)
Details
Future Maturities of Outstanding Notes Payable, Third Parties, Remainder of Current Year	$ 9,530,212
Future Maturities of Outstanding Notes Payable, Third Parties, Year Two	933,846
Future Maturities of Outstanding Notes Payable, Third Parties, Year Three	2,183,157
Future Maturities of Outstanding Notes Payable, Third Parties, Year Four	125,699
Future Maturities of Outstanding Notes Payable, Third Parties, Year Five	130,755
Future Maturities of Outstanding Notes Payable, Third Parties, Thereafter	4,149,006
Future Maturities of Outstanding Notes Payable, Third Parties	$ 17,052,675

Note 4 - Notes Payable and Li_6

Note 4 - Notes Payable and Line of Credit (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Nov. 30, 2019	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Apr. 08, 2021
Gain on forgiveness of debt		$ 4,307,291	$ 0	$ 4,896,573	$ 0
Gain (loss) on extinguishment of debt		0	$ 253,063	$ 803,079	$ 344,704
Line of Credit Facility, Borrowing Capacity, Description				During 2021, the Company entered into three revolving lines of credit totaling $8.3 million and two capital expenditures lines of credit totaling $1.0 million. The revolving lines of credit used as of September 30, 2021, totaled $3.7 million with an interest rate ranging from prime plus 2.50% - 4.25% and a term of one year. As of September 30, 2021, the Company had $5.6 in additional funds available to borrow.
Line of Credit Facility, Remaining Borrowing Capacity		$ 5,600,000		$ 5,600,000
Subordinated Secured Promissory Note 1
Debt Instrument, Face Amount	$ 1,900,000					$ 1,883,418
Debt Instrument, Interest Rate During Period	4.25%
Debt Instrument, Periodic Payment	$ 19,463
Subordinated Secured Promissory Note 2
Debt Instrument, Face Amount	$ 496,343
Debt Instrument, Interest Rate During Period	8.75%

Note 5 - Notes Payable, Relat_3

Note 5 - Notes Payable, Related Parties: Schedule of Notes Payable, Related Parties (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Notes payable, related parties	$ 3,000	$ 238,651
Notes Payable 1
Notes payable, related parties	3,000	3,000
Notes Payable 2
Notes payable, related parties	$ 0	$ 235,651

Note 6 - Convertible Notes Pa_4

Note 6 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Convertible Notes Payable	$ 7,500	$ 3,006,501
Debt Instrument, Unamortized Discount	0	(1,343,624)
Convertible Notes Payable, net of discount	7,500	1,662,877
Convertible notes payable, current	(7,500)	(562,242)
Convertible notes payable, net of current portion	0	1,100,635
Convertible Notes Payable 1
Convertible Notes Payable	7,500	25,000
Convertible Notes Payable 2
Convertible Notes Payable	0	1,291,463
Convertible Notes Payable 3
Convertible Notes Payable	0	7,538
Convertible Notes Payable 4
Convertible Notes Payable	0	200,000
Convertible Notes Payable 5
Convertible Notes Payable	$ 0	$ 1,482,500

Note 6 - Convertible Notes Pa_5

Note 6 - Convertible Notes Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 05, 2020	May 04, 2020
Convertible Notes Payable	$ 7,500			$ 3,006,501
Gain (Loss) on Extinguishment of Debt	803,079	$ 344,704
Debt Instrument, Convertible, Beneficial Conversion Feature	92,428	1,482,500
Amortization of debt discounts	$ 1,436,052	$ 507,534
Jeff Moss
Debt Instrument, Face Amount			$ 798,800			$ 720,185
Debt Conversion, Converted Instrument, Expiration or Due Date	May 4, 2027
Debt Instrument, Interest Rate During Period	5.00%
Debt Instrument, Periodic Payment	$ 2,605
Convertible Notes Payable				735,329
Dwight Hargreaves
Debt Instrument, Face Amount			$ 605,464		$ 551,001
Debt Conversion, Converted Instrument, Expiration or Due Date		Jun. 5, 2026
Debt Instrument, Interest Rate During Period		6.00%
Debt Instrument, Periodic Payment		$ 2,316
Convertible Notes Payable	$ 0			$ 556,135
Gain (Loss) on Extinguishment of Debt		$ 192,272

Note 6 - Convertible Notes Pa_6

Note 6 - Convertible Notes Payable: Schedule of Acitivity of Convertible Notes Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Details
Convertible Notes Payable, net of discount	$ 7,500		$ 1,662,877
Issuance of convertible notes payable for cash	408,000
Repayments of convertible notes payable	(1,680,964)	$ (270,294)
Conversion of notes payable to common stock	(1,726,037)
Amortization of debt discounts	1,436,052	$ 507,534
Discount from beneficial conversion feature	$ (92,428)

Note 7 - Stockholders' Equity (

Note 7 - Stockholders' Equity (Details) - USD ($)	Feb. 11, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Proceeds from the sale of common stock, net of offering costs							$ 54,302,982	$ 374,000
Stock Issued During Period, Value, New Issues					$ 124,000	$ 250,000
Stock Issued During Period, Value, Acquisitions			$ 2,535,071	$ 6,653,309
Stock price		$ 6					$ 6
Employee stock compensation							$ 31,933	$ 58,887
Unrecognized Stock Option Expense		$ 11,815					$ 11,815
Restricted Stock Units (RSUs)
Stock Repurchased During Period, Shares							514,286
TDI
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 7,456,394
Alt Labs
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							11,902,677
Vayu US
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 6,653,309
Common Class A
Stock Issued During Period, Shares, New Issues					3,000,000	3,941,753
Stock Issued During Period, Value, New Issues					$ 300	$ 394
Stock Issued During Period, Shares, Acquisitions			643,010
Conversion of Class C to Class A, Shares		1,617,067	1,617,067
Conversion of Class C to Class A, Shares		(1,617,067)	(1,617,067)
Conversion of Class B to Class A, Shares		350,000	350,000
Conversion of Class B to Class A, Shares		(350,000)	(350,000)
Stock Issued During Period, Value, Acquisitions			$ 64	0
Common Class A | TDI
Stock Issued During Period, Shares, Acquisitions							281,223
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 1,102,394
Common Class A | Alt Labs
Stock Issued During Period, Shares, Acquisitions							361,787
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 1,432,677
Common Class A | Investor
Stock Issued During Period, Shares, New Issues							1,524,064
Stock Issued During Period, Value, New Issues							$ 9,300,000
Stock Issued During Period, Shares, Conversion of Convertible Securities							7,384,018
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments							$ 1,886,898
Common Class C
Stock Issued During Period, Value, New Issues					0	0
Conversion of Class C to Class A, Shares		(1,617,067)	(1,617,067)
Conversion of Class C to Class A, Shares		1,617,067	1,617,067
Stock Issued During Period, Value, Acquisitions			$ 0	0
Common Class C | Investor
Stock Repurchased During Period, Shares							45,000
Stock Repurchased During Period, Value							$ 185,850
Common Class B
Stock Issued During Period, Value, New Issues					0	0
Conversion of Class B to Class A, Shares		(350,000)	(350,000)
Conversion of Class B to Class A, Shares		350,000	350,000
Stock Issued During Period, Value, Acquisitions			$ 0	$ 0
Series D Preferred Stock
Stock Issued During Period, Value, New Issues					0	0
Stock Issued During Period, Shares, Acquisitions				1,432,244
Stock Issued During Period, Value, Acquisitions			0	$ 143
Series D Preferred Stock | Vayu US
Stock Repurchased During Period, Shares							200,000
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 6,653,309
Stock price		$ 3.50					$ 3.50
Series C Preferred Stock
Stock Issued During Period, Value, New Issues					$ 0	$ 0
Stock Issued During Period, Value, Acquisitions			$ 0	$ 0
Series C Preferred Stock | Vayu US
Stock Repurchased During Period, Shares							314,286
Purchase Agreement
Sale of stock	8,333,333
Proceeds from the sale of common stock, net of offering costs	$ 45,000,000

Note 7 - Stockholders' Equity_5

Note 7 - Stockholders' Equity: Schedule of Common Stock Outstanding Roll Forward (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,790,000
Exercisable	1,556,126
Equity Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,790,000		1,790,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.19		$ 0.19
Weighted Average Remaining Contractual Term, Outstanding	6 years 4 months 2 days	7 years 1 month 2 days
Outstanding, Intrinsic Value	$ 3,599,255		$ 6,176,855
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	0
Forfeited	0
Vested and expected to vest	1,790,000
Weighted average price per share - Vested and Expected to Vest	$ 0.19
Weighted Average Remaining Contractual Term, Vested and Expected to Vest	6 years 4 months 2 days
Outstanding, Intrinsic Value, Vested and Expected to Vest	$ 3,599,255
Exercisable	1,556,126
Weighted average price per share - Exercisable	$ 0.21
Outstanding, Intrinsic Value, Exercisable	$ 3,097,221
Stock Option 1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	979,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.05
Weighted Average Remaining Contractual Term, Outstanding	6 years 10 months 17 days
Exercisable	761,063
Weighted average price per share - Exercisable	$ 0.05
Stock Option 2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	85,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.10
Weighted Average Remaining Contractual Term, Outstanding	6 years 6 months 10 days
Exercisable	69,063
Weighted average price per share - Exercisable	$ 0.10
Stock Option 3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	388,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.13
Weighted Average Remaining Contractual Term, Outstanding	5 years 10 months 2 days
Exercisable	388,500
Weighted average price per share - Exercisable	$ 0.13
Stock Option 4
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	114,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.26
Weighted Average Remaining Contractual Term, Outstanding	5 years 7 months 2 days
Exercisable	114,000
Weighted average price per share - Exercisable	$ 0.26
Stock Option 5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	223,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.90
Weighted Average Remaining Contractual Term, Outstanding	5 years 6 months 7 days
Exercisable	223,500
Weighted average price per share - Exercisable	$ 0.90

Note 7 - Stockholders' Equity_6

Note 7 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Outstanding		1,790,000
Exercisable		1,556,126
Warrant
Outstanding	275,000	275,000
Weighted average price per share	$ 1.01	$ 1.01
Weighted Average Remaining Contractual Term, Outstanding	3 years 4 months 20 days		2 months 23 days
Outstanding, Intrinsic Value	$ 0		$ 723,250
Granted		416,667
Weighted average price per share - Granted		$ 6.60
Forfeited		(275,000)
Weighted average price per share - Forfeited		$ 1.01
Exercised		0
Outstanding		416,667	275,000
Weighted average price per share		$ 6.60	$ 1.01
Vested and expected to vest		416,667
Weighted average price per share - Vested and Expected to Vest		$ 6.60
Weighted Average Remaining Contractual Term, Vested and Expected to Vest		3 years 4 months 20 days
Outstanding, Intrinsic Value, Vested and Expected to Vest		$ 0
Exercisable		0
Weighted average price per share - Exercisable		$ 0
Outstanding, Intrinsic Value, Exercisable		$ 0

Note 7 - Stockholders' Equity_7

Note 7 - Stockholders' Equity: Schedule Of Summary Of Warrants Outstanding And Exercisable (Details)	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Outstanding, Intrinsic Value, Exercisable	416,667
Warrants Exercisable	0
Warrant 2
Outstanding, Intrinsic Value, Exercisable	416,667
Warrants Exercisable	3 years 4 months 20 days
Warrants Outstanding, Weighted Average Exercise Price | $ / shares	$ 6.60
Warrants Exercisable	0
Warrants Exercisable, Weighted Average Exercise Price | $ / shares	$ 0

Note 7 - Stockholders' Equity_8

Note 7 - Stockholders' Equity: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	9 Months Ended
	Sep. 30, 2021$ / shares
Details
Stock price	$ 6
Risk-free interest rate	0.01%
Expected life of the options	4 years
Expected volatility	347.00%
Expected dividend yield	0.00%

Note 8 - Business Combination_3

Note 8 - Business Combination: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details)	9 Months Ended
	Sep. 30, 2021USD ($)
Vayu US
Cash	$ 81,442
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	50,000
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Intellectual Property	6,981,256
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Non-Solicitation Covenant	90,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	(411,539)
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Loan	(137,850)
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,653,309
Cash	(81,442)
Vayu US | Series D Preferred Stock
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,653,309
TDI
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	7,456,394
TDI | Business Acquisition, Accounts Receivable
Cash	1,408,682
Cash	(1,408,682)
TDI | Business Acquisition, Contract Asset
Cash	826,231
Cash	(826,231)
TDI | Business Acquisition, Property and Equipment
Cash	111,789
Cash	(111,789)
TDI | Business Acquisition Intangible Assets
Cash	4,820,000
Cash	(4,820,000)
TDI | Business Acquisition, Goodwill
Cash	3,528,621
Cash	(3,528,621)
TDI | Business Acquisition, Accounts Payable
Cash	786,151
Cash	(786,151)
TDI | Business Acquisition, Accrued Expenses
Cash	53,857
Cash	(53,857)
TDI | Business Acquisition, Contract liability
Cash	2,334,188
Cash	(2,334,188)
TDI | Business Acquisition, Notes Payable
Cash	64,733
Cash	(64,733)
TDI | Business Acquisition, Cash
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,354,000
TDI | Common Class A
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	1,102,394
Alt Labs
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	11,902,677
Alt Labs | Business Acquisition, Accounts Receivable
Cash	397,441
Cash	(397,441)
Alt Labs | Business Acquisition, Property and Equipment
Cash	1,739,441
Cash	(1,739,441)
Alt Labs | Business Acquisition Intangible Assets
Cash	10,410,000
Cash	(10,410,000)
Alt Labs | Business Acquisition, Goodwill
Cash	252,851
Cash	(252,851)
Alt Labs | Business Acquisition, Accounts Payable
Cash	397,441
Cash	(397,441)
Alt Labs | Business Acquisition, Accrued Expenses
Cash	62,242
Cash	(62,242)
Alt Labs | Business Acquisition, Contract liability
Cash	1,754,290
Cash	(1,754,290)
Alt Labs | Business Acquisition, Notes Payable
Cash	1,695,238
Cash	(1,695,238)
Alt Labs | Business Acquisition, Cash
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	10,470,000
Alt Labs | Business Acquisition, Inventory
Cash	2,621,653
Cash	(2,621,653)
Alt Labs | Business Acquisition, Other Asset
Cash	390,502
Cash	(390,502)
Alt Labs | Common Class A
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	$ 1,432,677

Note 8 - Business Combination_4

Note 8 - Business Combination: Business Acquisition, Pro Forma Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Sales	$ 17,398,316	$ 16,299,024	$ 49,465,682	$ 51,377,078
Cost of goods sold	12,104,134	12,020,468	35,183,907	37,090,187
Gross profit	5,294,182	4,278,556	14,281,775	14,286,891
Operating Expenses	6,966,642	4,855,978	21,474,825	17,294,094
Loss from operations	(1,672,460)	(577,422)	(7,193,050)	(3,007,203)
Net loss	$ 2,481,592	$ (809,618)	$ (3,892,897)	$ (2,742,963)
Loss per share	$ 0.01	$ (0.01)	$ (0.02)	$ (0.02)

Note 9 - Equity Investments_ _2

Note 9 - Equity Investments: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details) - AmplifeiIntl LLC	Sep. 30, 2021USD ($)
Business Acquisition, Accounts Receivable Converted
Cash	$ 1,000,000
Business Acquisition, Cash
Cash	$ 350,000

Note 10 - Segment Reporting_ _2

Note 10 - Segment Reporting: Schedule of Segment Reporting Information, by Segment (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Construction Services
Revenue	$ 5,465,881			$ 5,488,718			$ 15,565,332	$ 17,198,134
Gross Profit	678,702			343,965			1,392,904	2,753,554
Loss from operations	(607,794)			(529,896)			(3,464,327)	(195,470)
Depreciation, Depletion and Amortization, Nonproduction	240,966			389,269			995,014	1,099,834
Interest Expense	150,028			567,206			832,498	1,723,594
Net income (loss)	1,792,912			(1,027,073)			(881,293)	(1,240,693)
TOTAL ASSETS	16,681,507						16,681,507		$ 22,648,181
Goodwill	121,221						121,221		121,221
Accounts receivable, net	4,793,691						4,793,691		4,501,401
Manufacturing
Revenue	10,210,549			3,240,915			21,506,262	9,409,959
Gross Profit	3,128,290			995,262			6,672,549	2,301,433
Loss from operations	947,792			392,029			1,679,930	(886,867)
Depreciation, Depletion and Amortization, Nonproduction	469,419			153,271			1,049,042	455,714
Interest Expense	113,910			233,283			382,785	615,436
Net income (loss)	2,913,757			400,368			3,371,416	(1,145,527)
TOTAL ASSETS	43,804,926						43,804,926		10,731,936
Goodwill	2,216,612						2,216,612		1,963,761
Accounts receivable, net	7,205,449						7,205,449		1,983,468
Defense
Revenue	1,721,886			0			2,866,991	0
Gross Profit	641,144			0			1,101,362	0
Loss from operations	(135,575)			0			(131,953)	0
Depreciation, Depletion and Amortization, Nonproduction	87,322			0			143,539	0
Interest Expense	0			0			825	0
Net income (loss)	(120,481)			0			(114,097)	0
TOTAL ASSETS	11,319,049						11,319,049		0
Goodwill	3,528,621						3,528,621		0
Accounts receivable, net	991,089						991,089		0
Revenue	17,398,316			8,729,633			39,938,585	26,608,093
Gross Profit	4,448,136			1,339,227			9,166,815	5,054,987
Loss from operations	(1,672,460)			(572,051)			(9,648,746)	(3,281,893)
Depreciation, Depletion and Amortization, Nonproduction	1,178,805			553,060			2,851,969	1,582,604
Interest Expense	537,882			1,139,462			3,226,192	3,694,531
Net income (loss)	2,481,592	$ (3,127,277)	$ (6,129,468)	(1,399,862)	$ (2,562,914)	$ 250,388	(6,775,153)	(3,712,388)
TOTAL ASSETS	97,111,332						97,111,332		40,734,183
Goodwill	5,866,454						5,866,454		2,084,982
Accounts receivable, net	12,990,229						12,990,229		6,484,869
Aerospace
Loss from operations	(963,134)			0			(3,886,311)	0
Depreciation, Depletion and Amortization, Nonproduction	222,291			0			448,659	0
Net income (loss)	(963,134)			0			(3,456,780)	0
TOTAL ASSETS	14,332,809						14,332,809		6,342,863
Unallocated
Loss from operations	(913,749)			(434,184)			(3,846,085)	(2,199,556)
Depreciation, Depletion and Amortization, Nonproduction	158,807			10,520			215,715	27,056
Interest Expense	273,944			338,973			2,010,084	1,355,501
Net income (loss)	(1,141,462)			$ (773,157)			(5,694,399)	$ (1,326,168)
TOTAL ASSETS	$ 10,973,041						$ 10,973,041		$ 1,011,203